HDAC6 inhibition and deletion reduce COPD symptoms in mice and human airway epithelia
M. Lizé (Wuppertal, Germany), S. Horstmann (Wuppertal, Germany), V. Düsterhus (Wuppertal, Germany), C. Wiedwald (Göttingen, Germany), C. Ebert (Wuppertal, Germany), A. Addante (Wuppertal, Germany), C. Neideck (Wuppertal, Germany), S. Frank (Wuppertal, Germany), F. Sohler (Wuppertal, Germany), M. Koch (Wuppertal, Germany)
Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Lizé (Wuppertal, Germany), S. Horstmann (Wuppertal, Germany), V. Düsterhus (Wuppertal, Germany), C. Wiedwald (Göttingen, Germany), C. Ebert (Wuppertal, Germany), A. Addante (Wuppertal, Germany), C. Neideck (Wuppertal, Germany), S. Frank (Wuppertal, Germany), F. Sohler (Wuppertal, Germany), M. Koch (Wuppertal, Germany). HDAC6 inhibition and deletion reduce COPD symptoms in mice and human airway epithelia. 5033
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: